Partner Fund Management

Total investments

29

Average round size

84M

Portfolio companies

22

Rounds per year

1.45

Lead investments

4

Follow on index

0.24

Exits

17

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharmaBioinformatics

Investments analytics

Analytics

Total investments
29
Lead investments
4
Exits
17
Rounds per year
1.45
Follow on index
0.24
Investments by industry
  • Biotechnology (21)
  • Health Care (18)
  • Medical (16)
  • Therapeutics (6)
  • Pharmaceutical (6)
  • Show 10 more
Investments by region
  • United States (26)
Peak activity year
2017
Number of Unicorns
2
Number of Decacorns
2
Number of Minotaurs
3

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
497M
Group Appearance index
0.97
Avg. company exit year
5
Avg. multiplicator
4.17
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
bitkey Japan 23 Jan 2020 Information Technology, Security, CMS Early Stage Venture 10M Chiyoda, Japan
Karuna Therapeutics 18 Mar 2019 Biotechnology, Health Care, Pharmaceutical Early Stage Venture 68M United States, Massachusetts, Boston
Voyager Therapeutics 13 Apr 2015 Biotechnology, Health Care, Genetics, Life Science Early Stage Venture 60M United States, Cambridge, Massachusetts
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.